Epidemiology & Monitoring

COVID-19 pandemic related stress and Bacterial vaginosis infection among Secondary school girls in western Kenya

(P19) Diversity in sequence types of Chlamydia trachomatis and inflammatory profiles in adolescent girls and young women from Cape Town and Johannesburg, South Africa

(P21) Trends in Chlamydia trachomatis IgG seroprevalence in the general population of the Netherlands over 20 years

(P22) The Relationship Between Past Incarceration and Chlamydia Infection in Young Black Men in New Orleans

(P23) Increasing prevalence and clinical presentation of the new L2b/D-Da recombinant Chlamydia trachomatis lymphogranuloma venereum (LGV) strain in British Columbia, Canada

(P24) Systemic Anti-Chlamydial Antibodies do not Confer Protection from Extragenital Chlamydia trachomatis (CT) Infection

(P30) Validity of self-reported recent condomless sex among couples in Vietnam

(P31) Interventions promoting condom use among young heterosexual people: a systematic review

(P38) Impact of the COVID-19 pandemic on HIV and sexually transmitted infections testing and diagnosis in Lebanon

(P40) STI Rates among Patients Tested at a Community-Based Organization Before, During, and After CoVID Shutdowns

(P41) Impact of COVID-19 pandemic on sexually transmitted infections – a study from a tertiary care centre

(P42) Impact of the COVID-19 Pandemic on a Near Point of Care STI Management & Treatment

(P43) Lasting STI testing site closures and innovations from the COVID-19 Pandemic in a Midwestern City

(P44) Redirection of a COVID-19 contact tracing program: A pilot to expand gonorrhea and chlamydia partner services

(P45) The impact of the COVID19 pandemic on the quarterly numbers of STI tests among Medicaid patients using CMS Medicaid claims data, 2019-2020

(P46) Impact of the COVID-19 pandemic on HIV and syphilis screening and case characteristics in British Columbia, Canada: an Interrupted Time Series Analysis

(P47) STI Rates among a University Student Population Before, During, and After Covid-19 Shutdowns

(P48) Covid-19 Stay at Home Period Effects on Provider Visits and HIV Viral Load Results

(P49) Impact of the COVID-19 pandemic on syphilis in Germany

(P50) Trends in STI testing and diagnosis rates during the COVID-19 pandemic at a large urban tertiary care center, and the role of the emergency department in STI care

(P51) Overall impact in sexually transmitted infection testing due to stay-home orders by states in the early phases of U.S. COVID-19 pandemic using administrative claims data from 2019-2020.

(P57) Antimicrobial Resistance of Neisseria gonorrhoeae in Germany 2016-2022

(P58) Antimicrobial susceptibilities of Neisseria gonorrhoeae in Canada, 2017-2021

(P59) Patterns of antimicrobial susceptibility in Neisseria gonorrhoeae from 5 cities in Vietnam

(P60) Molecular antimicrobial resistance surveillance of Neisseria gonorrhoeae in Germany

(P61) Azithromycin use and antimicrobial resistance in Neisseria gonorrhoeae before and after a national treatment guideline change, King County, WA, USA, 2017-2022

(P63) The Enhanced Gonococcal Antimicrobial Surveillance Program (EGASP) reveals increasing cases of meningococcal urethritis among males in sentinel clinics in Metro Manila, Philippines

(P64) High background level of a reduced susceptible phenotype to extended-spectrum cephalosporins in oropharyngeal Neisseria species in a setting without ceftriaxone resistant Neisseria gonorrhoeae

(P65) Minimum inhibitory concentration (MIC) creep of selected antimicrobials used for treating Neisseria gonorrhoeae observed in an urban setting in the Philippines from July 2018 to June 2022

(P66) Despite absence of ceftriaxone resistance in the Netherlands many oropharyngeal Neisseria gonorrhoeae isolates have a mosaic penA gene similar to commensal Neisseria species

(P67) Trends in Tetracycline Resistance in Neisseria gonorrhoeae as Sexually Transmitted Infection Demands for Doxycycline Increase, Gonococcal Isolate Surveillance Project (GISP), 1987 - 2022*

(P68) Gonorrhoea Undetected Resistance Laboratory Study (GURLS): a case-finding study for ceftriaxone-resistant Neisseria gonorrhoeae in England

(P69) Reduced susceptibility of pharyngeal Neisseria gonorrhoeae infections to current recommended therapeutics in England and Wales using national surveillance data (GRASP)

(P88) The epidemiology of Neisseria gonorrhoeae in the Middle East and North Africa: Systematic review, meta-analyses, and meta-regressions

(P89) Epidemiology of Neisseria gonorrhoeae in Australia, New Zealand, and the Pacific Islands: Systematic review, meta-analyses, and meta-regressions

(P90) Neisseria gonorrhoeae and hypertensive disorders of pregnancy: Is there effect modification by maternal characteristics?

(P91) Genital and Extragenital Chlamydia and Gonorrhea infections among Men and Women from a Clinical trial Evaluating Test Performance in Extragenital Samples

(P92) Census tract-level social vulnerability and gonorrhea in Ohio: results from the STD Surveillance Network 2020-2021

(P93) Epidemiology of Neisseria gonorrhoeae in Europe: Systematic review, meta-analyses, and meta-regressions

(P94) Anorectal Neisseria gonorrhoeae infection in a large population of women tested at sexual health centres in the Netherlands

(P95) Trends in Estimated Rates of Reported Neisseria gonorrhoeae Cases by Anatomic Site, Seven U.S. Jurisdictions, STD Surveillance Network, 2016 – 2021

(P96) Disseminated Neisseria gonorrhoeae cases in Canada, 2016-2021

(P97) Incidence of repeat gonorrhea diagnoses and associated characteristics, SSuN Network, 2016-2019

(P98) Epidemiology of Neisseria gonorrhoeae in Asia: Systematic review, meta-analyses, and meta-regressions

(P108) Optimizing healthcare resource allocation for HIV testing in China

(P109) Missed Opportunities for Concurrent HIV and Syphilis Testing Among Patients At-Risk for STIs in a Large, Urban, Safety Net Hospital

(P138) Trends in Resource Utilization for Emergency Department Visits Associated with HIV in the United States, 2009 to 2019

(P139) Understanding the Burden of Antimicrobial Resistance among HIV Patients in Nigeria: A Systematic Review

(P140) Time above 1500 copies/mL: potential for ongoing transmission among patients linked to HIV care from public Sexual Health Clinics

(P141) Sentinel surveillance to assess HIV/HCV coinfection prevalence across Southern Texas

(P142) Impact of HIV on the Latinx Community in San Antonio

(P144) STI prevalence among young adults diagnosed with HIV in childhood and adulthood: a cross-sectional survey in Zimbabwe

(P146) Factors Associated with Self-Reported HIV Testing and HIV positivity Among Young Black Men Having Sex with Women in New Orleans, LA

(P148) Using the Medical Monitoring Project to Assess Uptake of Sexually Transmitted Infection Screening and Prophylaxis among People Living with Diagnosed HIV

(P161) High-risk human papilloma virus among HIV-negative men who have sex with men in Benin, West Africa

(P162) Disparities in HPV vaccination among trans women in Brazil

(P163) A Retrospective Chart Review of Anal Dysplasia Screening Practices among High-Risk Populations in an Academic Medical System

(P164) HPV prevalence and risk factors among Women Living with HIV attending public health services in Brazil: pilot implementation of HPV-DNA tests based on self-collection of vaginal samples

(P171) Does Genital Herpes Symptom History Predict Herpes Simplex Virus Type 2 Antibody Positivity?

(P172) Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: Systematic review, meta-analyses, and meta-regressions

(P180) STI Testing and Time to Reinfection Among Residents In An Urban Juvenile Detention Center 2016-2019

(P182) Sexual health and sexually transmitted infections prevention among people who have sex between vulvas: a Brazilian analysis

(P183) Are sexual minority women more at risk for rectal sexually transmitted infections than their heterosexual counterparts? STD Surveillance Network, January 2020-August 2022

(P194) How use of a cut-off index (COI) helps clinicians manage reactive HIV test results that arise from service users accessing Sexual Health London (SHL), a regional STI/HIV postal testing service

(P207) Sexually Transmitted Infections Among Persons with Mpox in Brazil from June to December 2022

(P208) Monkeypox among People Living with HIV, Chicago, IL June 1-November 30, 2022.

(P209) The impact of the mpox epidemic on the trends of sexually transmitted infections among male HIV positive individuals and HIV PrEP users in Belgium. Results from an STI clinic.

(P210) Characteristics of Mpox infections in Louisiana in the 2022 Outbreak

(P211) Monkeypox/Syphilis coinfection- is this the new challenge in combating the Great Imitator?

(P212) Development and Validation of Machine Learning and Deep Learning Models to Identify Human Monkeypox

(P213) Lack of detectable antibodies to mpox in infected individuals

(P214) Extragenital chlamydia and gonorrhea among persons diagnosed with mpox in Chicago, Illinois (June 1, 2022-September 17, 2022)

(P216) Evaluation of Public Health Contact Tracing for Mpox — Ten U.S. Jurisdictions, May 17–July 31, 2022

(P217) Low prevalence of asymptomatic Mpox virus in men attending sexual health services for HIV pre-exposure prophylaxis in England

(P233) Neisseria gonorrhoeae and Chlamydia trachomatis positivity by symptom status and anatomic site of infection among men who have sex with men in a HIV Pre-exposure Prophylaxis program in Hanoi, Vietnam

(P234) Patient outcomes and perceptions of partner services among MSM diagnosed with early syphilis in King County, WA

(P235) The impact of COVID-19 on Sexual and HIV testing behaviors among MSM tested for HIV in China: A Serial Trend Analysis

(P236) Sex toy sharing and post-exposure prophylaxis (PEP) among gay, bisexual and other men having sex with men (GBM); results from the Engage Cohort Study

(P237) Comparing men who have sex with women, men who have sex with men only and men who have sex with men and women visiting a public STD clinic

(P247) Mycoplasma genitalium Antimicrobial Resistance Surveillance (MARS): protocol for a national surveillance programme in England

(P248) Mycoplasma Genitalia Testing During Admission In An Urban Juvenile Detention Center 2022

(P250) Antimicrobial resistance in Mycoplasma genitalium: preliminary results of the first Brazilian study

(P251) The real magnitude of antimicrobial resistance of Mycoplasma genitalium in Belgium.

(P252) Prevalence of urogenital Mycoplasma genitalium and associated factors in a sample of US Army service members and their dependents

(P258) Network Testing in Southside of Chicago: Identifying Challenges in a Post-COVID Era

(P259) Characterising the spatiotemporal burden of symptomatic sexually transmitted infections in Malawi

(P263) Partner treatment preferences and outcomes at three timepoints among pregnant women treated for Chlamydia trachomatis and Neisseria gonorrhoeae in Botswana

(P264) Factors associated with ability to recontact prior sex partners for treatment among young Black men with chlamydia in New Orleans, LA

(P265) Trends in Early Syphilis Partner Notification Services in Heterosexual Men, Pregnant Women, and Non-Pregnant Women from 2014-2021, North Carolina, US

(P275) National trends of Mother-to-child transmission of HIV, hepatitis B, and syphilis in Brazil from 2011 to 2021

(P277) Prevalence and incidence of Chlamydia trachomatis and Neisseria gonorrhoeae among pregnant women in a high HIV prevalence setting in South Africa

(P278) Could Vaginal pH Testing Reduce Excess Antibiotic Use Among Pregnant Women with Vaginal Discharge Syndrome?

(P279) Effect of antenatal Chlamydia trachomatis and Neisseria gonorrhoeae screening on post-delivery prevalence and vertical transmission in Gaborone, Botswana

(P280) Prenatal syphilis and HIV screenings in the early third trimester have increased following new legislation in Michigan

(P297) Barriers and Facilitators of HIV Pre-Exposure Prophylaxis Services in an Obstetrics-Gynecology Clinic in Alabama: A Qualitative Analysis

(P298) Loss to follow-up in the Dutch PrEP pilot program

(P299) Association of provider type with sexually transmitted infection (STI) occurrence and pre-exposure prophylaxis (PrEP) non-adherence among key adolescent populations in Brazil

(P300) Evaluating Pre-Exposure Prophylaxis Uptake, Adherence and Persistence Outcomes among Adolescents and Young Adults Aged 10-24: A Global Systematic Review, Meta-analysis, and Meta-synthesis.

(P302) Improved PrEP delivery among all populations during the COVID 19 pandemic in a traditional sexual health clinic

(P303) Newly diagnosed HIV and use of HIV-PrEP among migrant MSM attending STI clinics in the Netherlands, a retrospective cohort study

(P315) Systematic review of the applications for individual clinical management and care of whole genome sequencing for human pathogens

(P334) Online testing over samples population groups with the greatest STI risk

(P335) Reasons individuals initially engaging with an online sexually-transmitted and blood-borne infection testing service do not test: implications for service design and implementation

(P336) Self-Collected Specimens for STI Screening and Related Research among People Who Use Illicit Opioids in New York City

(P337) Self-sampling and self-testing for HIV at a commercial and community test service in the Netherlands: usability and user preferences

(P354) Infections with extensively antibiotic resistant Shigella sonnei and identification based on whole genome sequencing in Germany

(P355) Co- prevalent sexually transmitted infections among individuals presenting with genital ulcer disease in Zimbabwe

(P356) Etiologies of Genital Ulcer Disease among Sexually Transmitted Infections Clinic Patients in Lilongwe, Malawi

(P357) Proportion of Asymptomatic Sexually Transmitted Infections in Women in Low- and Middle-Income Countries: a Systematic Review and Meta-Analysis

(P358) Sexually transmitted infection burden among cohabitating heterosexual couples in southern Uganda: a population-based study

(P359) County-level persistent poverty as a predictor of gonorrhea and chlamydia incidence

(P360) Estimating quality-adjusted life years (QALYs) lost due to five sexually transmitted diseases in the United States

(P361) High prevalence of genital and isolated extragenital sexually transmitted infections in vulnerable female populations in Ecuador

(P362) Co-infection Rate of Sexually Transmitted Infections from a United States Cohort

(P365) Etiological molecular identification of sexually transmitted infections that cause urethral discharge and genital ulcer in Brazilian men: a nationwide study.

(P366) Pilot implementation of the National Service for C. trachomatis, N. gonorrhoeae, T. vaginalis, and M. genitalium molecular tests: Preliminary prevalence and Risk Factors Among Pregnant Women in Brazil

(P367) Recurrent Chlamydia and Gonorrhea Infections in US Army Soldiers: 2015-2019

(P368) Risk factors for curable sexually transmitted infections among youth: findings from a population survey in Zimbabwe

(P369) STI/HIV burden and sexual healthcare-seeking behaviour among first- and second-generation migrant and Western-born male sex workers who have sex with men in the Netherlands between 2016-2021

(P370) STI/HIV burden and sexual healthcare-seeking behaviour among first- and second-generation migrant and Western-born female sex workers in the Netherlands: a retrospective cohort study

(P371) Social determinants of health and sexually transmitted infection disparities in California, 2013 - 2021

(P375) Prevalence of, and factors associated with, HIV, syphilis, chlamydia and gonorrhoea in individuals tested in walk-in clinics in North-Rhine Westphalia, Germany, in 2021

(P376) Prevalence of five curable sexually transmitted infections and associated risk factors among young gay, bisexual and other men who have sex with men in urban Kenya: a respondent-driven sampling survey

(P413) Analysis of mutations associated with tetracycline resistance and molecular typing of Treponema pallidum strains from syphilis patients in Lima, Peru

(P409) Differences in syphilis positivity according to geographic areas of south Brazil

(P410) Barriers to syphilis treatment among transwomen in Brazil

(P411) Syphilis prevalence and correlates in rural, southwestern Uganda

(P417) Cytokine levels seven days post treatment among patients with active syphilis in Peru

(P412) Factors Associated with Self-Reported Syphilis Testing Among Young Black Men Having Sex with Women in New Orleans, LA

(P414) Compliance with syphilis treatment and follow-up in a retrospective cohort in south Brazil

(P415) Clinical, microbiologic, and molecular epidemiology of early syphilis in Southwestern Colombia – implications for vaccine development

(P416) Trends in Primary and Secondary Syphilis among Females in Chicago, 2017-2021

(P418) Characterising a syndemic among women impacted by syphilis and the toxic drug supply in Fraser Health Authority, Canada using latent class analysis

(P419) HIV and syphilis testing for heterosexuals aged above 25 years in the Netherlands: possibilities for targeted testing at Sexual Health Centers

(P420) Evaluation of reported primary and secondary syphilis cases among areas prioritized by the Ending the HIV Epidemic initiative — United States, 2020

(P421) Repeat Primary and Secondary Syphilis Infections in 10 U.S. Jurisdictions, STD Surveillance Network, 2020 – 2021

(P422) Living Off the Grid: Automating Syphilis Electronic Laboratory Processing to Align with Case Definition in Florida, USA

(P423) Syphilis prevalence among people living with HIV in Sub-Saharan Africa: A systematic review and meta-analysis

(P424) Population-based trends in syphilis testing from Manitoba, Canada: 2015-2022.

(P429) Congenital Syphilis Elimination: Even harder during a pandemic

(P430) How did Congenital Syphilis case characteristics change between 2018 and 2021 in Louisiana, a high morbidity state in the US?

(P432) Social Vulnerabilities Associated with Congenital Syphilis

(P433) Missed Opportunities for Congenital Syphilis Prevention in a Missouri Hospital System

(P435) Evaluation of Universal Syphilis Screening at Delivery in British Columbia, Canada

(P436) Syphilitic Stillbirths and Syphilitic Neonatal Deaths in Florida, USA, 2012-2021

(P445) Strain variation of Trichomonas vaginalis amongst street and brothel-based female sex workers in Ecuador

(P447) Associations between intravaginal and menstrual hygiene practices and Trichomonas vaginalis among women living with HIV in Zambia

(P448) Prevalence and incidence of Trichomonas vaginalis in pregnant women in South Africa

(P468) Sexually Transmitted Infections and Bacterial Vaginosis among Women of Child-Bearing Age in Antananarivo, Madagascar: Prevalence and Risk Factors

(P469) Assessment of the performance of a multiplex real-time PCR, AmpliSens Florocenosis/Bacterial Vaginosis-FRT, versus Nugent's criteria in the diagnosis of BV in women in Mozambique

(P470) Amsel-BV before and after a single exposure to lubricant during transvaginal ultrasound and incidence of Amsel-BV over 10 weeks compared to a lubricant-unexposed cohort

(P471) Comparison of computer-assisted self-interview (CASI) versus clinician-interview (CI) for self-reported vulvovaginal symptoms

(P472) Association between diabetes and the vaginal microbiota

(P473) Social and Behavioral Predictors of Recurrent Bacterial Vaginosis among Women Attending Sexual Health Clinics in New York City from 2014-2018

(P475) Trends in and factors associated with having bacterial vaginosis and vulvovaginal candidiasis among women attending the Melbourne Sexual Health Centre, 2012-2021

(P480) PILOT IMPLANTATION OF A MOLECULAR BIOLOGY NETWORK TO DETECT CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE IN THE BRAZILIAN NATIONAL HEALTHCARE SYSTEM

(P492) Racial and Ethnic Differences in Chlamydia and Gonorrhea Testing Locations among Medicaid-Insured Youth

(P494) Self-reported uptake of STI testing services among adolescents and young people aged 15-24 in Lusaka, Zambia: findings from the Yathu Yathu trial

(P496) A preliminary examination of longer-term non-infectious conditions associated with chlamydia and gonorrhea infections in adolescence and young adulthood

(P6-LB) Factors associated with chemsex and sexually transmitted infection positivity in individuals attending self-screening clinics: A cross-sectional study in Québec, Canada

(P70-LB) Extended-spectrum ß-lactamase and macrolide resistance in Neisseria gonorrhoeae in western Kenya

(P99-LB) Large surge in gonorrhoea diagnoses among heterosexual young people with a high proportion of throat infections

(P149-LB) MEASURING THE IMPACT OF TEEN CLUB IN MWANZA, TANZANIA: PRELIMINARY RESULTS FOR MEDICATION ADHERENCE AND CLINICAL MARKERS

(P151-LB) Self-perception of HIV infection risk and its associated factors in the general population of a southern Brazilian state.

(P238-LB) Association of STI screening and prevalent STI cases in MSM at a Sexual Health Clinic

(P316-LB) Using a Secure Text-based Patient Messaging Platform to Recruit Community Clinic Patients for Participation in a Public Health Led Study on Mpox Vaccine Effectiveness.

(P426-LB) Knowledge towards syphilis among urban adults in Rio Grande do Sul, Brazil: preliminary results from a population-based cross-sectional household survey

(P443-LB) Heterogeneity in HIV and STI outcomes among transgender and non-binary patients attending New York City Sexual Health Clinics, 2018-2022

(P449-LB) Trichomoniasis testing amongst women in Maryland who self-Collect specimens through a mail-in STI testing program (IWantTheKit)